MSD to push for approval of HIV combo after Phase III success
MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.
Qureight and Remedy Cell to validate RC-0315 in Phase Ib trial for IPF
Ascletis’ muscle-preserving weight loss therapy sustains 40-day half-life
Gilead to launch Phase III once-yearly HIV PrEP trial after Phase I success
Seismic Therapeutic doses first healthy participant cohort in Phase I trial of S-1117
OSE announces overall survival success in Phase II PDAC vaccine trial
Analysis
View More
Themes
View MoreMWC Barcelona 2025: Maximizing 5G network value in the age of AI
At MWC Barcelona 2025, Li Peng, Huawei's Corporate Senior Vice President and President of ICT Sales & Service, delivered a keynote on how carriers can make the most of AI...
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
1 of 2
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Driving bioscience innovation: How Teesside University empowers industry breakthroughs
The AI advantage in discovering new medicines
JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline
JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic